1. Homepage
  2. Equities
  3. Spain
  4. Bolsas y Mercados Espanoles
  5. Grifols, S.A.
  6. News
  7. Summary
    GRF   ES0171996087

GRIFOLS, S.A.

(GRF)
  Report
Delayed Bolsas y Mercados Espanoles  -  11:38 2022-08-12 am EDT
13.76 EUR   -0.61%
08/04European ADRs Move Higher in Thursday Trading
MT
08/03European ADRs Nudge Higher in Wednesday Trading
MT
07/29European ADRs Move Higher in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Fall Sharply in Thursday Trading

06/30/2022 | 11:15am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMARIN CORPORATION PLC 2.48% 1.65 Delayed Quote.-51.04%
AUTOLUS THERAPEUTICS PLC 3.18% 3.57 Delayed Quote.-31.21%
AVADEL PHARMACEUTICALS PLC 1.02% 6.93 Delayed Quote.-14.23%
BICYCLE THERAPEUTICS PLC 1.31% 26.25 Delayed Quote.-56.88%
BIONTECH SE 1.11% 160.35 Delayed Quote.-37.80%
CARNIVAL CORPORATION 1.71% 10.72 Delayed Quote.-46.72%
DBV TECHNOLOGIES -2.82% 4.99 Real-time Quote.63.13%
EDAP TMS S.A. 2.32% 7.49 Delayed Quote.25.04%
ENDAVA PLC 3.69% 114.41 Delayed Quote.-31.87%
FORWARD PHARMA A/S 0.27% 3.76 Delayed Quote.-37.02%
GRIFOLS, S.A. -0.61% 13.755 Delayed Quote.-18.49%
NATUZZI S.P.A. 15.17% 8.58 Delayed Quote.-46.14%
SAP SE 0.25% 93.03 Delayed Quote.-25.52%
STMICROELECTRONICS N.V. 0.32% 37.125 Real-time Quote.-14.40%
TRINITY BIOTECH PLC 2.17% 1.41 Delayed Quote.-1.40%
VERONA PHARMA PLC 15.17% 13.59 Delayed Quote.102.23%
All news about GRIFOLS, S.A.
08/04European ADRs Move Higher in Thursday Trading
MT
08/03European ADRs Nudge Higher in Wednesday Trading
MT
07/29European ADRs Move Higher in Friday Trading
MT
07/28European ADRs Decline in Thursday Trading
MT
07/28Grifols, S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June..
CI
07/28Spain's Grifols Sells MedKeeper Assets for $93 Million; Stock Drops 6%
MT
07/281H 2022 Consolidated interim financial statements
AQ
07/281H2022 Earnings results
AQ
07/28Grifols sold MedKeeper to affiliates of the US company Becton Dickinson for US$ 93 mill..
AQ
07/28GRIFOLS, S.A. : Half-year report
CO
More news
Analyst Recommendations on GRIFOLS, S.A.
More recommendations
Financials
Sales 2022 5 772 M 5 918 M 5 918 M
Net income 2022 324 M 332 M 332 M
Net Debt 2022 8 519 M 8 735 M 8 735 M
P/E ratio 2022 28,1x
Yield 2022 0,40%
Capitalization 8 057 M 8 261 M 8 261 M
EV / Sales 2022 2,87x
EV / Sales 2023 2,49x
Nbr of Employees 27 584
Free-Float 79,7%
Chart GRIFOLS, S.A.
Duration : Period :
Grifols, S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GRIFOLS, S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 13,76 €
Average target price 21,87 €
Spread / Average Target 59,0%
EPS Revisions
Managers and Directors
Raimon Grifols Roura Joint Chief Executive Officer & Executive Director
Victor Grifols Deu Joint Chief Executive Officer & Executive Director
Alfredo Arroyo Guerra Chief Financial Officer & Vice President
Víctor Grifols Roura Non-Executive Chairman
Xavier Sueiras Gil Chief Information Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
GRIFOLS, S.A.-18.49%8 261
CSL LIMITED0.73%100 197
SAMSUNG BIOLOGICS CO.,LTD.0.78%49 647
WUXI BIOLOGICS (CAYMAN) INC.-23.45%38 544
BIOGEN INC.-7.89%32 069
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-21.03%23 349